JP Morgan Cuts Altera to Neutral

Analyst Christopher Danely thinks the company's earnings guidance is too aggressive

JP Morgan cut its investment recommendation on Altera (ALTR ) to neutral from overweight, citing the company's recently announced quarterly results.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.